Randomized Phase II Trial to Compare the Efficacy of Haloperidol and Olanzapine in the Control of Chemotherapy-Induced Nausea and Vomiting in Nepal | Zendy

Soniya Dulal | Zendy; Bishnu Dutta Paudel | Zendy; Prakash Neupane | Zendy; Aarati Shah | Zendy; Bibek Acharya | Zendy; Bishesh Sharma Poudyal | Zendy; Ramila Shilpakar | Zendy; Lori Wood | Zendy

Open Access

Randomized Phase II Trial to Compare the Efficacy of Haloperidol and Olanzapine in the Control of Chemotherapy-Induced Nausea and Vomiting in Nepal

Author(s) -

Soniya Dulal,

Bishnu Dutta Paudel,

Prakash Neupane,

Aarati Shah,

Bibek Acharya,

Bishesh Sharma Poudyal,

Ramila Shilpakar,

Lori Wood

Publication year - 2019

Publication title -

journal of global oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.002

H-Index - 17

ISSN - 2378-9506

DOI - 10.1200/jgo.18.00245

Subject(s) - olanzapine , nausea , medicine , vomiting , randomized controlled trial , haloperidol , chemotherapy induced nausea and vomiting , chemotherapy , dopamine antagonist , psychiatry , antiemetic , schizophrenia (object oriented programming) , dopamine

The purpose of the study was to compare efficacy and toxicity of olanzapine (OLN; a higher-cost drug) and haloperidol (HAL; a lower-cost drug) in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients who receive highly emetogenic chemotherapy (HEC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research